Skip to content

Proactive 21 April 2022

Artrya brings AI-driven heart disease diagnostic tool to the US market with subsidiary spin off

John Barrington discusses the company’s move into the US market, and its use of artificial intelligence in diagnosing early indicators for heart disease in clinical settings.